MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Renal cell carcinoma treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,551 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,551 works in the cohort · of 4,299,418page 33 of 52

Labels cover 11 of 2,551 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,551 of 2,551 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

venueno affunlabeled
Management of Locally Advanced Renal Cell Carcinoma
В. Б. Матвеев, Sarah P. Psutka, Grant D. Stewart, Gennady Bratslavsky, E. Jason Abel
2022· article· en· Société Internationale d’Urologie Journal· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affgemma · no categorygpt · no categorymodels agree
Isolated brain metastasis from a small renal mass
Christopher J.D. Wallis, Michelle R. Downes, Georg A. Bjarnason, Raj Satkunasivam
2016· article· en· BMJ Case Reports· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affvenueaboutunlabeled
Renal Cell Carcinoma in the Canadian Indigenous Population
Emily C L Wong, Rodney H. Breau, Ranjeeta Mallick, Lori Wood, Frédéric Pouliot, Naveen S. Basappa +7 more
2019· article· en· Current Oncology· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affaboutunlabeled
Renal cell carcinoma in children. Prognostic factors
Mohammad Al‐Shabanah, Derek R Jenkin, Yasser O Khafaga, Ali Alzahrani, Cyril Danjoux, Mark Greenberg
2004· article· en· Saudi Medical Journal· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
venueno affunlabeled
Impact of the Discordance Between Scales of Memorial Sloan-Kettering Cancer Center and International Metastatic Renal Cell Carcinoma Database Consortium in Patients’ Prognosis With Metastatic Renal Cancer
Hiram Josué Grimaldo-Roque, Erika Adriana Martinez-Castañeda, Mariana G. Morales-Garcia, Jorge Luis Leal-Hidalgo, Valeria M. Torres-Guillen, Rita Dorantes-Heredia +2 more
2022· article· en· World Journal of Oncology· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
Preliminary Assessment of a Renal Tumor Materials Model
Alfonso Fernandez, Elvis C. S. Chen, John Moore, Terry M. Peters, Carling Cheung, Petar Erdeljan +3 more
2011· article· en· Journal of Endourology· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
venueno affunlabeled
A rare case of spontaneous necrosis of primary renal cell carcinoma
Kyosuke Matsuzaki, Ryoichi Imamura, Toshichika Iwanishi, Masahiro Nakagawa, Go Tanigawa, Koichi Tsutahara +4 more
2015· article· en· Canadian Urological Association Journal· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
TiNivo-2: A phase 3, randomized, controlled, multicenter, open-label study to compare tivozanib in combination with nivolumab to tivozanib monotherapy in subjects with renal cell carcinoma who have progressed following one or two lines of therapy where one line has an immune checkpoint inhibitor.
Toni K. Choueiri, Laurence Albigès, Rana R. McKay, Sumanta K. Pal, Hans J. Hammers, Daniel Yick Chin Heng +3 more
2022· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
CABOSEQ 3—Comparison of Cabozantinib versus Sunitinib Following First-Line Nivolumab- Ipilimumab for Metastatic Renal Cell Carcinoma: A Target Trial Emulation Using Real-World Data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)
Audreylie Lemelin, David Maj, Kosuke Takemura, Devon J. Boyne, Matthew T. Warkentin, Darren R. Brenner +14 more
2025· article· en· Clinical Genitourinary Cancer· Medicine
machine prediction:candidate · noneconsensus · none
3
citations

How this was built: Screen · Findings · About